Thunen Shelley B's Form 4 filing
RxSight, Inc. (RXST) · filed Jan 3, 2024
- Accession no.
- 0000950170-24-000892
- Filed
- Jan 3, 2024
- Trade date
- Jan 2, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $392.4K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Thunen Shelley BCIK 0001297491 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2024 | Common Stock | MOption exerciseAcquired | +10,000 | $15.60 | +$156,000 | 12,291 | Direct | |
| Jan 2, 2024 | Common Stock | SSaleDisposed | −4,519 | $38.77F2 | −$175,201.63 | 7,772 | Direct | |
| Jan 2, 2024 | Common Stock | SSaleDisposed | −5,481 | $39.63F3 | −$217,212.03 | 2,291 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2024 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 66,805 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average share price of an aggregate total of 4,519 shares sold in the price range of $38.295 to $39.20 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average share price of an aggregate total of 5,481 shares sold in the price range of $39.35 to $40.01 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.